John Austin
Analyst · BMO Capital Markets. Please proceed with your question
Thanks, Chris. And good afternoon, everyone. Our net sales for the quarter ended June 24, 2016 increased approximately 3.7% to $291.2 million, from the $280.9 million for the second quarter ended June 26, 2015. The increase in net sales was the result of organic growth of approximately 2.3%, as well as one additional week of sales from the acquisition of Del Monte that we closed in April of 2015, which added approximately 1.4% to sales growth for the quarter. Inflation deceased approximately 188 basis point sequentially, as we experienced deflation of approximately 1.2% for the quarter. While we expect the deflation in proteins for the year, our core specialty division turned modestly deflationary in the second quarter. Our overall outlook for commodities for the balance of 2016 is that protein deflation will moderate somewhat, and specialty products will likely stay relatively flat with mixed inflation and deflation by product category. Gross profit increased approximately 0.1% to $71.8 million for the second quarter of 2016, versus $71.7 million for the second quarter of 2015. Gross profit margin decreased approximately 88 basis points to 24.7% from 25.5%. Total gross profit margins were negatively impacted by margins in our protein division, which decreased 175 basis points, as well a 44 basis point decline in our specialty division. Total operating expense decreased approximately 2.8% to $60.6 million for the second quarter of 2016, from $62.4 million for the second quarter of 2015. As a percentage of net sales, operating expenses were 20.8% for the second quarter of 2016, compared to 22.2% for the prior year quarter. The decrease in the Company's operating expense ratio is largely attributable to the lower transaction costs of $3.3 million related to the company's acquisition of Del Monte in 2015. And a net year-over-year reduction in the estimated fair value of earn-out obligations of approximately $1.7 million, offset in part by approximately $1.7 million of higher warehouse labor and occupancy related costs associated with accompanying new warehouses. More specifically G&A expenses decreased to approximately $17.9 million for the second quarter of 2016, compared to $22.5 million for the prior year quarter, due mostly to the lower transaction related costs related to the Del Monte deal, as well as a change in the estimated fair value of earn-out liabilities I just mentioned. Operating income for the second quarter of 2016 was $11.2 million, compared to $9.3 million for the second quarter of the prior year. As a percentage of net sales, operating income was 3.8% for the second quarter of 2016, compared to 3.3% for the prior year second quarter. Interest expense increased to $25.7 million versus $3.6 million for the prior year second quarter, due to the refinancing we completed in June. That transaction included a $22.3 million loss related to the early extinguishment of debt, which consisted primarily of prepayment penalties to repay our senior secured notes, and also the write off of deferred financing fees on our revolving credit facility. We believe this new capital structure gives us incremental capacity for acquisitions, as well as flexibility as we grow. Income tax provided a benefit of $6.0 million for the second quarter of 2016, compared to income tax expense of $2.4 million in the second quarter of 2015. Our effective tax rate remained flat at approximately 41.6%. Our GAAP net loss was $8.5 million, or $0.33 per diluted share for the second quarter of 2016, compared to $3.4 million, or $0.13 per diluted share for the second quarter of 2015. Again, this was driven primarily by the one-time loss on the early extinguishment of debt related to refinancing of our capital structure. On a non-GAAP basis, adjusted EBITDA was $15.3 million for the second quarter of 2016, compared to $18.7 million for the prior year second quarter. Modified pro forma net income was $3.9 million, and modified pro forma EPS was $0.15 for the second quarter of 2016, compared to modified pro forma net income of $5.7 million, or $0.21 per share for the second quarter of the prior year. As I just mentioned, we entered into a new $305 million term loan facility, and a $50 million delayed draw term loan facility due in 2022. In addition, we entered into a five year $75 million asset-backed revolving credit facility. Proceeds from the new term loan were used to refinance our existing revolving credit facility, and to retire our outstanding senior secured notes. The proceeds of the delayed draw term loan will be used for permitted acquisitions, and for general corporate purposes. The interest rate on the new term loan is LIBOR plus 4.75%, with a LIBOR floor of 1.0%, the new term loans with a 1% percent original issue discount. Based on our second quarter results, we are updating guidance for fiscal year 2016. This guidance contemplates a significantly slower recovery than we previously expected in our protein division, and also incorporates a softer restaurant industry that we previously discussed. We estimate that net sales for the full year of 2016 to be in the range of $1.18 billion to $1.20 billion, which includes the benefits of the M&T acquisition, offset by the slower expected sales growth I just mentioned. Adjusted EBITDA between $53.0 million and $58.5 million, which contemplates the lower top line growth as well as lower protein margins. The GAAP net loss between $1.0 million and $3.0 million, which reflects the loss on extinguishment of debt that I earlier talked about. GAAP net loss per diluted share will be between $0.01 and $0.09 per share, and modified pro forma net income per diluted share between $0.38 and $0.46. This guidance is based on an effective tax rate of approximately 41% to 41.5% for 2016, and an estimated diluted share count of approximately 27.25 million shares. Note that for purposes of calculating the modified pro forma diluted EPS, the company has assumed the convertible debt will be diluted for the full year, and as such has added back $537,000 of interest after tax to net loss, and assumed conversion into 1.2 million shares related to that convertible note, and we have included those in the diluted weighted average shares. With that, Operator, we will turn it over for questions.